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ABSTRACT 
The effect of the specific beta-adrenergic receptor 
agonist 1-isoproterenol on renin release and c-AMP content 
of kidney slices from sodium-replete and sodium-deficient 
rats was studied in vitro. Male, Sprague-Dawley rats 
weighing 210±1og were fed high sodium (over 2.2 mEg/L) or 
low sodium (less than 0.02 mEg/L) diets for periods of time 
of 2-3 weeks. Following decapitation, renal cortical slices 
weighing so±20mg were incubated for 1 hour at 37°C in 
Robinson's buffer medium with or without (control) the 
various pharmacological agents. Isoproterenol doses ranging 
from lo-13M to 10- 3M did not affect renin release or c-AMP 
content in slices from sodium-replete rats. In contrast, 
isoproterenol doses from 10-7M to 10- 3M significantly in-
creased renin release and c-AMP content in slices from 
sodium-deficient rats, whereas concentrations lower than 
10- 7M were ineffective. Addition of the beta-adrenergic 
-4 
receptor blocker d,l-propranolol (10 M) to slices from 
sodium deficient rats prevented stimulation of renin release 
and c-AMP content by 10-7M isoproterenol but only partially 
inhibited the effect of a higher isoproterenol dose (10- 3M). 
In the same slices, addition of the alpha-adrenergic receptor 
-6 blocker phentolamine (10 M) prevented the stimulatory 
-7 -3 
effect of two isoproterenol doses (10 M and 10 M) on renin 
release. Its effect on c-AMP content, however, was only 
partial, since in the presence of phentolamine plus iso-
proterenol (10- 7M), tissue c-AMP content levels remained 
significantly elevated. It should be pointed out, however, 
that although phentolamine appeared to prevent the stimu-
-7 -3 latory effect of 10 M and 10 M isoproterenol on renin 
release, the mean renin secretory rates observed in the 
presence of this blocking agent plus the two doses of 
isoproterenol were no different from those seen with iso-
proterenol added alone, but the standard errors were larger 
in the former. 
These data indicate that: 1) sodium deficiency 
potentiates the renin release and c-AMP responses to added 
isoproterenol; 2) isoproterenol appears to stimulate renin 
release in a dose-response relationship; 3) isoproterenol 
stimulates renin release in sodium deficient rats by a 
beta-adrenergic receptor mechanism mediated by the genera-
ii 
tion of intracellular c-AMP; 4) alpha-adrenergic receptors 
may partly mediate the stimulatory effect of isoproterenol 
on renin secretion, instead of mediating an inhibitory 
effect as proposed for high norepinephrine concentrations in 
other studies. 
iii 
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CHAPTER I 
INTRODUCTION 
During the past decade, the importance of neural 
sympathetic mechanisms in the regulation of renin secretion 
has been clearly demonstrated in vitro (1-10) and in vivo 
(11-15) and has been discussed at length in a number of 
review articles (16-18). Nevertheless, substantial progress 
has been slowed by the difficulty of separating these neural 
factors from the various humoral and hemodynamic ones 
which influence renin secretion. It is generally accepted 
that renin secretion is partly regulated by norepinephrine, 
the catecholamine released from sympathetic nerve terminals, 
via a beta-adrenergic receptor complex. This complex 
appears to be located on the membranes of the juxtaglo-
merular cells themselves, and may utilize cyclic-3'5'-
adenosine monophosphate (c-AMP) as the intracellular 
mediator of renin release by norepinephrine. 
Several studies (7, 9, 10, 15) have also shown 
that in addition to its stimulatory effect on renin release 
at physiological and subphysiological concentrations which 
appears to be beta-receptor mediated, high concentrations of 
norepinephrine may exert an inhibitory effect on renin 
release. This inhibitory effect of norepinephrine on renin 
release may be mediated by renal alpha-adrenergic receptors 
(8, 9, 15) through a decrease in intracellularly generated 
c-AMP (9). The significance of these opposite effects of 
norepinephrine on renin release is not clear at this 
time. 
This investigation examines some of the mechanisms 
by which the sympathetic nervous system regulates renin 
secretion from the juxtaglomerular cells of the mammalian 
kidney. Although this research is basic in nature it has 
important clinical implications as well, particularly with 
regard to hypertensive disorders characterized by a chronic 
maladjustment of the renin secretory mechanisms (i.e. 
high-renin hypertension) which may be neurally mediated to 
a significant degree (18, 19). 
Overall, these experiments are designed to evalu-
ate the effects of a specific beta-adrenergic receptor 
agonist, isoproterenol (20), either alone or coupled with 
alpha- and beta-adrenergic receptor blockade on renin 
release. Examination of these effects has been accomplished 
2 
by means of an in vitro rat renal cortical slice prepara-
tion, obtained from rats maintained on sodium-replete or 
sodium-deficient diets for 2-3 weeks (7, 9). 
Specifically, these experiments will attempt to 
determine whether or not: 1) isoproterenol stimulates renin 
secretion primarily via a beta-adrenergic receptor pathway, 
mediated by c-AMP and involving new synthesis of renin as 
suggested for norepinephrine (4, 5, 7, 9) rather than by a 
preferential membrane effect not involving de ~ synthesis 
of renin (21); 2) beta-adrenergic receptor blockade by 
d,l-propranolol inhibits isoproterenol-stimulated renin 
release, as suggested for norepinephrine and other cate-
cholamines (4); 3) renal alpha-adrenergic receptors play a 
role in inhibiting isoproterenol-stimulated renin release, 
3 
as recently suggested by some investigators regarding 
norepinephrine (8, 9); 4) there is a correlation between 
c-AMP and renin release changes in response to isoproterenol, 
which would constitute strong evidence for a beta-adrenergic 
receptor pathway mediating renin secretion via intracell-
ularly generated c-AMP and de ~ synthesis of renin; and 
5) sodium deficiency potentiates the renin secretory 
responses to isoproterenol, as suggested from various in 
vivo and in vitro studies with regard to other catechola-
mines (9, 12). 
4 
CHAPTER II 
LITERATURE REVIEW 
It is now well established that renin release is 
regulated by several interrelating factors. These factors, 
described by Davis (17), include the following: 1) the 
intrarenal receptors, composed of the baroreceptors of the 
renal afferent arteriole, and the macula densa natrio-
receptors located in the walls of the distal convoluted 
tubule of the kidney; 2) humoral agents such as sodium, 
potassium, calcium, antidiuretic hormone, angiotensin-II, 
c-AMP and the circulating catecholamines epinephrine and 
norepinephrine from the adrenal medulla; 3) the sympathetic 
nervous system, via catecholamines released from renal 
sympathetic nerve endings. 
A. The Renin-Angiotensin System 
Renin, a hormone synthesized and released from the 
juxtaglomerular cells of the afferent arteriole of the 
kidney, is involved in the control of blood pressure, fluid 
volume and electrolyte balance (17, 22-26). That the jux_ 
taglomerular cells are indeed vascular smooth muscle 
5 
cells modified to serve an endocrine function was first 
suggested by Goormagtigh (27). Laragh (26) and Liddle et. 
al (28) have recently reviewed the renin-angiotensin system 
biochemical pathway, which is initiated by endogenous renin 
acting enzymatically on the tetradecapeptide angiotensinogen 
(renin substrate), a gamma globulin synthesized in the 
liver, to liberate the decapeptide angiotensin-! by hy-
drolysis of the C-terminal tetrapeptide of angiotensinogen. 
Angiotensin-! in turn is cleaved by a converting enzyme 
found in large amounts in the pulmonary circulation, 
liberating the octapeptide angiotensin-II, considered to be 
the most powerful pressor agent in the systemic circulation. 
In addition to its effects on blood pressure, angioten-
sin-II has been postulated as being a potent stimulator of 
the synthesis and secretion of aldosterone, a mineralo-
corticoid from the adrenal cortical glomerulosa cells (2, 
29). However, recent evidence by Vaughan (30) have sug-
gested that angiotensin-III, a circulating heptapeptide 
derived from angiotensin-II, may be the actual modulator of 
aldosterone synthesis and release. 
6 
B. Intrarenal Receptors 
Tobian et. al (22) have suggested that a decreased 
stretch of the afferent arteriole as a result of changes 
7 
in perfussion pressure, leads to an increase in renin release. 
Using a non-filtering, denervated kidney coupled with adrenal-
ectomy, which effectively eliminated macula densa, renal 
nerve catecholamines and circulating catecholamine effects, 
respectively, Blain and Davis (25) observed a significant 
increase in renin release in response to a moderate hemorrhage 
(20ml/kg), thus supporting the baroreceptor hypothesis. 
Vander and Miller (31) first suggested that the 
macula densa cells of the distal convoluted tubule are 
sensitive to changes in sodium "load" or concentration. In 
their experiments with anesthetized dogs, they observed that 
the increase in renin secretion caused by aortic constric-
tion was no longer seen upon administration of diuretic 
agents. They therefore suggested that diuretic agents 
increase the sodium load at the macula densa thus inhibiting 
renin release. They further proposed that renin release is 
stimulated by a decreased sodium load at the macula densa, 
and that the macula densa cells function as effective natrio-
receptors. Nash (32) has supported this macula densa theory 
this macula densa theory by showing that in dogs having 
their ureters blocked, infusion of sodium chloride solutions 
resulted in a significant decrease in renin secretion. 
C. Humoral and Hemodynamic Effects on Renin 
Release 
Further experiments by Vander (33) on the effects 
of potassium on renin secretion have shown that infusion 
of potassium chloride solutions into normal or salt-depleted 
dogs caused a decrease in renin release. Potassium is 
postulated to inhibit renin release indirectly by inhibiting 
proximal tubule sodium reabsorption which would, in turn, 
increase the sodium load at the macula densa. 
Furthermore, Michelakis et. al (1) have shown that 
c-AMP added to incubated kidney cell suspensions resulted 
in a greater net production of renin than cells incubated 
without c-AMP, suggesting a possible direct effect of this 
nucleotide on renin secretion. More recent investigations 
by Saruta et. al (34) have provided added evidence for a 
stimulatory role of c-AMP on renin secretion. The same 
workers have additionally suggested that calcium also 
plays a stimulatory role on renin release. However, most 
of the evidence concerning the possibility of a direct 
8 
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effect of ions on renin release is still controversial and 
further studies are clearly needed. 
The mechanisms by which angiotensin-II and anti-
diuretic hormone (ADH) inhibit renin release have been 
reviewed by Shade et. al (35). Using sodium-depleted dogs 
with a nonfiltering kidney they found a decrease in renin 
secretion after infusion of angiotension-II and ADH, sug-
gesting that the action of these humoral agents may be 
exerted directly on the juxtaglomerular cells, which supports 
previous work by Bunag et. al (11). While the possibility 
of a direct mechanism of action of ADH on renin secretion 
remains largely unclear, these studies and others (9) gene-
rally show that angiotensin-II appears to exert a direct 
regulatory control over renin release by a short-loop nega-
tive feedback of locally-generated angiotensin-II on the 
juxtaglomerular cells. It has also been suggested that this 
inhibitory effect of angiotensin-II is mediated by a decrease 
in intracellularly generated c-AMP (9). 
D. The Sympathetic Nervous System and Renin 
Secretion 
Evidence is accumulating that the sympathetic 
nervous system is a very important modulator of renin 
10 
secretion, not only for the minute-to-minute control in 
the healthy individual, but in pathological states as well 
(18, 19, 36). 
Electron microscopic (37) and fluorometic studies 
(38) have provided clear evidence for a dense sympathetic 
innervation of the juxtaglomerular cells, suggesting the 
possibility of a direct stimulation of renin secretion by 
released norepinephrine from sympathetic nerve endings and 
perhaps by its released precursors (dopamine) as well. 
In vivo experiments by Vander (39) confirmed these early 
observations by showing that electrical stimulation of the 
renal nerves significantly increased plasma renin activity. 
Johnson et. al (40) have supported these findings by 
showing that direct stimulation of the renal nerves resulted 
in a concomitant increase in renin secretion. Passo et. al 
(41) additionally found that stimulation of the medulla 
oblongata increased plasma renin activity and that this 
response was prevented by renal dennervation. 
Investigations concerning the effects of cate-
cholarnines on renin release (17) have shown that the 
circulating catecholamines epinephrine and norepinephrine 
released from the adrenal medulla, as well as norepine-
11 
phrine released from renal sympathetic nerve endings, 
stimulate renin release and that this reponse may be medi-
ated by a beta-adrenoreceptor pathway. Evidence for the 
existence of a beta-adrenoreceptor mechanism mediating renin 
release has been obtained from the studies of Loeffler et. 
al (42) who showed that in dogs given 1-propranolol, a known 
beta-adrenoreceptor blocker, renin release produced by renal 
nerve stimulation was significantly decreased. Moreover, 
Assaykeen et. al (13) observed that as a result of hypo-
glycemia produced in dogs, which increased the levels of 
circulating catecholamines, renin secretion was abolished 
upon injection of 1-propranolol. The same workers addi-
tionally showed that following administration of phento-
lamine, an alpha-adrenorector blocker, renin secretion was 
potentiated above control levels. 
However, these in vivo findings cannot eliminate the 
possibility of other in vivo factors participating in the 
observed responses. Thus, in order to evaluate the possi-
bility of a direct action of the sympathetic nervous system 
on renin secretion, in vitro systems have been designed 
which effectively eliminate the contribution of humoral, 
hemodynamic and other in vivo influences. Using an in 
12 
vitro renal cortical slice preparation, Nolly et. al (4) 
have shown that added norepinephrine stimulates renin 
release, and that this stimulation appears to be mediated by 
a beta-adrenoreceptor complex located on the membranes of 
the juxtaglomerular cells. Furthermore, Nolly et. al. (4) 
provided additional evidence for their postulation by 
showing that the addition of theophylline, an inhibitor of 
the phosphodiesterase enzyme that ordinarily degrades 
intracellular c-AMP (43), resulted in a potentiation of the 
renin release responses to added norepinephrine. This 
suggests that norepinephrine may exert its action on renin 
release via a beta-adrenoreceptor mechanism which utilizes 
c-AMP as the intracellular mediator. Numerous other in 
vitro workers are in agreement with this proposed mechanism 
of action (1, 5-7, 44). Nolly et. al (4) have also shown 
that norepinephrine-stimulated renin release is potentiated 
by the addition of phentolamine and phenoxybenzamine, both 
of which are alpha-adrenoreceptor blocking agents. This may 
suggest a contribution of alpha-adrenoreceptors in the 
regulation of renin secretion which may be inhibitory in 
nature. 
13 
These in vitro observations have been further 
extended by Ganong and Lopez (9) who showed that the sig-
nificant stimulatory effect of low (lo-12M to 10-7M) nore-
pinephrine doses on in vitro renin secretion in sodium-
deficient rats was accompanied by concomitant increases in 
tissue c-AMP content. This constitutes additional evidence 
for a beta-adrenoreceptor mechanism mediating renin 
secretion. Conversely, the same workers have shown that 
high (10- 4M) norepinephrine doses were inhibitory to renin 
release and that this response is coupled with a significant 
decrease in tissue c-AMP levels. They have suggested, as 
well as others (3, 8, 15), that this inhibitory effect of 
high norepinephrine concentrations on renin release may be 
alpha-adrenoreceptor mediated since simultaneous addition of 
specific alpha-adrenoreceptor blockers (e.g. phentolamine) 
effectively reversed the inhibition (8, 9). 
On the other hand, Winer et. al (45) have presented 
evidence suggesting that alpha-adrenoreceptors actually 
mediate the stimulatory effect of catecholamines on renin 
secretion. 
In vitro studies by Ganong and Lopez (9) have shown 
that the renin secretory responses to added norepinephrine 
14 
are potentiated under sodium-deficient conditions, sup-
porting previous in vivo data (12). Most studies pertaining 
to renin secretion have utilized animals maintained on a 
commercial chow diet. However, a commercial chow diet 
contains approximately 12 times the recommended amount of 
sodium by the National Research Council. This obviously 
would result in a much lower basal renin release in these 
animals since renin release is extremely sensitive to plasma 
sodium levels. On the other hand, animals maintained on 
sodium-deficient diets show a much higher rate of basal 
renin release (7, 46) which appears to be due to an in-
creased de ~ synthesis; this has been shown by the elegant 
electron microscopic studies of Reidel (47). Moreover, in 
vivo (11, 12) and in vitro studies (7, 9) have suggested 
that sodium-deficient conditions, in addition to increasing 
the basal renin secretory rate, potentiate the renin secre-
tory reponses to sympathetic stimuli. Thus, the evaluation 
of both stimulatory and inhibitory effects of various 
adrenergic agents on renin secretion in animals maintained 
on sodium-deficient diets may be more easily ascertained, in 
view of the apparent greater sensitivity of the juxtaglo-
merular cells coupled with the higher resting renin release 
rates seen in the sodium-deficient state. 
15 
E. Isoproterenol and Renin Secretion 
Numerous studies on the effects of isoproterenol, 
a catecholamine with postulated specific beta-adrenoreceptor 
stimulating properties (20), have presented conflicting 
evidence as to the actual mechanism mediating its stimu-
latory effect on renin secretion. 
In vitro studies by Weinberger et. al (5) have shown 
that isoproterenol stimulates renin release and that this 
effect is blocked by the addition of 1- and d,l-propranolol 
but not by d-propranolol, which has all the properties of 
1-propranolol except its beta-blocking ability. Similar 
results have been reported by Capponi and Valloton (8} who 
showed that the significant stimulatory effect of isopro-
terenol on renin release was inhibited by d,l-propranolol, 
which constitute clear evidence for a beta-adrenoreceptor 
mechanism of action of this catecholamine. Other investi-
gators (44, 48) have further suggested that the stimulatory 
effect of isoproterenol on renin secretion is mediated by 
changes in intracellularly generated c-AMP and involves de 
novo synthesis of renin; this is consistent with a beta-
adrenoreceptor mechanism of action. 
16 
Assaykeen et. al (49) have also shown in anesthetized 
dogs that administration of phentolamine during isoproterenol 
infusion did not cause a reduction in renin. However, the 
addition of 1- and d,l-propranolol effectively prevented the 
increase in renin secretion seen during isoproterenol infusion. 
These data add support to a beta-adrenoreceptor mediated 
mechanism of action. 
In contrast to the possibility of an adenylate-cyclase 
complex mediating the renin release responses to isoproterenol, 
Johns and Singer (21) have indicated that the stimulatory 
effect of isoproterenol on renin release may preferentially 
be a membrane effect. They indicate that this leads to the 
output of preformed cytoplasmic renin granules without any 
involvement of an adenyl-cyclase-containing receptor complex; 
thus, without de ~ synthesis of renin. Partially in 
agreement with this view is the work by Beck (50) who has 
suggested that the renin-releasing effect of isoproterenol 
can be dissociated from the renal increase in c-AMP. 
Conversely, Reid et. al (14) have reported that 
although intravenous infusion of isoproterenol caused a 
significant increase in renin secretion, no increase was 
observed during intrarenal infusion. They, therefore, 
suggested the existence of an extrarenal receptor mechanism 
mediating the renin secretory responses to the infused 
isoproterenol, the location of which has not been proposed. 
17 
In any case, isoproterenol may eventually be considered 
to be another important regulator of renin secretion, par-
ticularly in view of the finding by Lockett et. al (51) of a 
substance that appears to be isoproterenol in the extracts 
of rat adrenal glands. This suggests the interesting possi-
bility that isoproterenol may be an endogenous secretory 
product of the adrenal medulla, and thus capable of partici-
pating in the minute-to-minute regulation of renin secretion 
in the body. 
CHAPTER III 
~~TERIALS AND METHODS 
Male, Sprague-Dawley rats (Sprague-Dawley, Co.) 
weighing 210±1og were utilized for the exper~ents. They 
were maintained in temperature-controlled rooms (23±2°C), 
two animals per cage, and had access to distilled-deionized 
water ad libitum. The animals were divided into two groups 
of 24 each, which were subsequently studied in two different 
experimental trials. The first group of 24 rats was further 
divided into two equal subgroups, each subjected to a specific 
dietary regime in which sodium was the only variable. Thus, 
one subgroup of 12 rats was fed a normal sodium chow diet 
(Purina) for 2-3 weeks while the other subgroup was fed a 
sodium-deficient diet (TEKLAD TEST, Co.) for a similar 
period of time. The second group of 24 rats, utilized in 
later experiments, was fed only a sodium-deficient diet for 
a period of 2-3 weeks. 
At the end of the specific dietary intake period, 
animals from the first group were sacrificed by decapi-
tation, and their kidneys rapidly excised, decapsulated and 
18 
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gassed with a mixture of 95% o2-5% co2 (52) while being 
maintained in Robinson's buffer medium at 4°C. Slices of 
renal cortex approximately 0.3mrn thick were prepared using a 
Stadie-Riggs microtome (A. Thomas, Co.) and divided into 
five similar portions, each weighing approximately so±2omg, 
which were randomly assigned to incubating flasks to assure 
a homogeneous population of cells. The slices were then 
preincubated for 15 minutes in 2.5ml of Robinson's buffer 
medium at 37°C in an atmosphere saturated with 95% o2-5% 
co2 using a Dubnoff shaking incubator (Precision Scientific, 
Co.). They were subsequently transferred to similarly 
numbered flasks containing fresh Robinson's at 37°C at which 
time the catecholamine was added. L-Isoproterenol (Sigma), 
prepared in 0.1% ascorbic acid to prevent oxidation of the 
catecholamine (5), was added in concentrations ranging from 
lo-13M to 10-3M in order to test for a dose response. This 
was followed by a 60 minute incubation period at 37°C with 
continuous 95% o2-5% co2 gassing and shaking. One flask 
from each group of slices served as an untreated control. 
After one-hour incubation the supernatant medium was collec-
ted and stored at -20°C until assayed, while the tissue was 
immediately frozen on dry-ice, homogenated in l.Oml of 8% 
TCA (trichloroacetic acid) and subsequently extracted with 
water-saturated ether (Mallinckrodt) . The ether phase was 
then discarded and the c-N1P containing water phase was 
subsequently lyophyllized and measured for c-AMP content 
using a modification of the competitive protein binding 
assay of Gilman (53). Briefly, the assay was performed as 
follows: fifty microliters of the unknown lyophyllized 
samples, previously diluted in 250 microliters of buffer 
(Tris/EDTA), were analyzed in duplicate along with 100 
microliters of binding protein purified from bovine muscle 
(Amersham) and 50 microliters of 3H-c-AMP (Amersham). The 
samples were then incubated for 90 minutes at 4oc· at which 
time 200 microliters of charcoal suspension (Amersham) were 
added which separated protein-bound from free c-AMP. The 
samples were then vortexed for 5 seconds and immediately 
centrifuged in a Sorvall RC2-B refrigerated centrifuge for 
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10 minutes at 10,000 X G, also at 4°C. At this time 200 
microliters of the supernatant were transferred into counting 
vials (Scientific Products) containing 10.0 ml of ACS-liquid 
scintillation cocktail (Amersham) , shaken and then allowed 
to settle in the dark for approximately 30 minutes prior to 
counting. Counting was done in a Packard liquid scintillation 
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counter for 5 minutes with the background counts subtracted. 
The values for the unknown samples were read from a standard 
curve and the amount in picomoles of c-AMP (read off the 
curve) were multiplied by a factor of 5 (i.e. dilution 
factor due to 1:5 dilution of sample in Tris/EDTA buffer) 
and divided by the milligrams of wet tissue weight to give 
the final concentration in pmol c-AMP content/mg wet tissue. 
In turn, renin in the incubated supernatant medium 
was measured by radioimmunoassay (RIA) of angiotensis-I and 
expressed as nanograms A-I generated/mg wet tissue/hour 
incubation. The supernatant samples were prepared for the 
RIA desribed as follows: plasma from 24-hour nephrectomized 
dogs was utilized as the source of renin substrate (angio-
tensinogen) . Appropriate amounts of the converting enzyme-
angiotensinases inhibitor agent, PhenylMethylSulfonylFluoride 
(Sigma) , were added to the nephrectomized plasma to prevent 
catabolism of angiotensin-! or its conversion to angio-
tensin-II. One milliliter of this mixture was added to 25 
microliters of sample (renin-supernatant) , and angioten-
sin-! was generated for 2 hours in a water bath at 37°C. At 
the end of the 2-hour generation period, one ml of distilled-
deionized water was added to the tubes and the samples were 
then boiled for three minutes. The samples were subse-
quently stored at -20°C until assayed for angiotension-I by 
RIA (Squibb). In short, the angiotensin-! RIA was done as 
follows: duplicate tubes containing unknown amounts of 
sample (25, 50, or 100 microliters), one ml of 125r-Angio-
tensin-I (approximately 5,000 counts per minute) and 50 
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microliters of angiotensin-! antiserum were incubated at 4°C 
for 24 hours. At this time, one ml of charcoal suspension 
adjusted to ph 5.5 with O.lN HCl were added to separate 
antibody-bound from free angiotensin-!, vortexed for 5 
seconds and centrifuged for three minutes at 10,000 X G at 
4°C. The supernatant was then transferred to test tubes 
(Scientific Products) and counted in a gamma counter (Pack-
ard) for two minutes with the background counts subtracted. 
Percent-bound values for the unknown samples were used as an 
index to determine the picogram amounts of angiotensin-! 
from a standard curve. The final angiotensin-! concen-
tration in the unknown samples were expressed as ng A-I 
generated/mg wet tissue/hr (see Appendix A). 
Slices of renal cortex from the second group of rats 
were similarly prepared and divided into six similar por-
tions with one serving as control. They were also treated 
in the same manner as those from the first series of studies. 
However, in this instance, a specific beta-adrenoreceptor 
blocker d,l-propranolol (Sigma), prepared in 0.1% ascorbic 
-4 
acid to a concentration of 10 M, and an alpha-adreno-
receptorblocker, phentolamine mesylate (Regitine, CIBA), 
also prepared in 0.1% ascorbic acid to a concentration of 
10- 6M, were added both before the pre-incubation (15 min.) 
and incubation (60 min.) periods. These agents were evalu-
ated when added either alone or in the presence of four 
different isoproterenol concentrations (lo-11 , 10- 9 , 10-7 , 
and 10-3M). Supernatant and tissue samples were collected, 
prepared and stored in a manner identical to those from the 
first series of studies and subsequently analyzed for the 
same parameters as previously described. 
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The data collected from these series of studies were 
analyzed for statistical significance using a modified 
paired student's T test (54) with the aid of a desk-top 
programmable calculator (Hewlet-Packard). 
CHAPTER IV 
RESULTS 
In a preliminary investigation, the effect of 
dietary sodium changes on renin release and the c-AMP 
content of rat kidney tissue was examined using the pre-
viously described renal cortical slice preparation. These 
data can be seen in Figure 1. As observed, the basal, 
non-stimulated, renin release rate in slices from sodium-
deficient rats was significantly greater (p 0.01) than that 
seen in slices from sodium-replete animals. There were not 
significant differences, however, between both dietary 
groups of slices in regard to the c-AMP content of the 
tissue in response to dietary sodium manipulation. 
In a subsequent study, the effect of various concen-
trations of the specific beta-adrenergic receptor agonist 
1-isoproterenol on renin secretion and c-AMP content of 
renal cortical slices from sodium-replete rats was evalu-
ated. The results can be seen in figure 2. The data from 
this experiment shows that at these various concentrations 
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(10 - 13 lo-3 ) . 1 . ff . . . M to M , ~soprotereno was ~ne ect~ve ~n st~mu-
lating renin release from the incubated kidney slice tissue. 
However, it is also apparent from these data (figure 2) that 
as the concentration of isoproterenol was progressively 
increased, the mean renin secretory values of the isopro-
terenol-treated slices became increasingly greater than the 
mean values of the non-stimulated control slices. In the 
same study, changes in c-AMP content of the kidney slices in 
response to the same concentrations of isoproterenol (figure 
3) were also not significantly different from controls, an 
observation which is consistent with the renin secretory 
responses shown in figure 2. 
Significant changes in the parameters examined were 
observed in another study, when isoproterenol at various 
-13 -3 
concentrations (10 M to 10 M) was added to kidney slices 
from sodium-deficient rats (figure 4). As shown in this 
figure, although isoproterenol doses of 10- 9M or lower were 
still ineffective in stimulating renin secretion, higher 
concentrations of this catecholamine (10- 7M, 10-5M, l0-4r-1, 
and 10-3M) significantly stimulated renin release, with the 
highest mean renin release values seen at a concentration of 
10- 5M). A statistical comparison among the four stimulatory 
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concentrations of isoproterenol indicated, however, that 
there were not significant differences between them in 
regard to stimulation of renin secretion. When their 
effects on renin release were compared to those exerted by 
-12 -9 lower isoproterenol concentrations (10 M to 10 M) a 
dose-response relationship was apparent. Thus, maximal 
stimulation of renin secretion was achieved with an isopro-
terenol dose as low as 10-7M; higher doses were ineffective 
in further potentiating the stimulatory effect (figure 4). 
When the renin release responses to added isopro-
terenol (figure 4) were compared with those exerted by the 
same concentrations of this catecholamine on tissue c-AMP 
content (figure 5), an apparent positive correlation between 
these two parameters was observed. These data show that at 
concentrations of 10-7M, 10-5M, and 10-3M, isoproterenol 
significantly stimulated both renin release and the c-AMP 
content of renal slices from sodium deficient rats. At 10-4M 
concentration, however, isoproterenol exerted a significant 
stimulatory effect only on renin release but not on c-AMP 
content. As expected, changes in c-AMP content of the 
isoproterenol-treated tissue slices were not significantly 
different from controls at isoproterenol concentrations of 
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10- 9M or lower. This is consistent with the changes seen in 
renin secretion in response to the same doses of this cate-
cholamine (figure 5). 
Data from a subsequent study designed to further 
evaluate the extent of beta-adrenoreceptor control of renin 
release are depicted in figure 6. This figure shows the 
changes observed in renin release and c-AMP content of 
slices from sodium-deficient rats in response to four 
isoproterenol doses (lo-11M, 10-9M, 10-7M, and 10-3M), added 
either alone or in conjunction with a 10-4M concentration of 
the beta-adrenoreceptor blocking agent d,l-isoproterenol. 
As expected, when added together with two isoproterenol 
-11 -9 doses (10 M and 10 M) which by themselves were ineffective 
in stimulating either renin release or c-AMP content, pro-
pranolol did not affect the response observed with isopro-
terenol alone. Conversely, when propranolol was added in 
conjunction with a 10-7M isoproterenol dose, it signifi-
cantly inhibited the stimulatory effect of this concentra-
tion of isoproterenol on renin release and c-AMP content. 
When added together with a higher isoproterenol dose (10- 3M), 
-4 however, propranolol at the concentration used (10 M) was 
unable to inhibit the significant stimulatory effect of this 
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catecholamine on renin secretion, although it did prevent 
the increase in c-AMP content seen with this dose of isopro-
terenol added alone. Surprisingly, addition of propranolol 
by itself to the slice preparation significantly decreased 
the c-AMP content of the tissue in relation to the non-
stimulated control samples, although it did not signifi-
cantly affect renin secretion as compared to control values. 
Table 1 illustrates the results of an additional 
study designed to evaluate the effect of the alpha-adreno-
receptor blocking agent phentolamine (10-6M), on the renin 
release and c-AMP content responses to four isoproterenol 
-11 -9 -7 -3 doses (10 M, 10 M, 10 M, and 10 M) in slices from 
sodium-deficient rats. Although when added alone to the 
slice preparation, phentolamine did not alter renin secre-
tion or c-AMP content levels in relation to those of con-
trols, it did partially prevent the stimulatory effect of 
10-? d 10-3 . 1 . . M an M 1soprotereno concentrat1ons on ren1n 
release when added in conjunction with the catecholamine. 
However, the c-AMP content of slices treated with 10-7M 
isoproterenol plus 10-6M phentolamine remained significantly 
elevated in relation to controls, but it appeared no dif-
-3 ferent from controls in response to 10 M isoproterenol 
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added in conjunction with phentolamine. It should be noted, 
however, that the mean renin secretion change levels of 
slices treated with 10-7M and 10- 3M isoproterenol in con-
junction with phentolamine, were equal to or greater than 
the statistically significant ones observed in response to 
the same doses of isoproterenol added alone, but the stan-
dard errors were larger in the former. From these data 
(Table 1), it is also clear that at no time phentolamine 
potentiated the effects of any of the isoproterenol doses on 
renin secretion or c-AMP content of the slice tissue, when 
added together with the catecholamine. 
TABLE I: Effect of various doses of isoproterenol 
absence of phentolamine (10- 6M) on renin secretion 
deficient rats. 
-3 10- 3M -7 ph=g· 10 H iso. 10 H 
10 M iso. 10-6M phen. iso. 
* + +** +.as± +2.23:!: + 1. 33± Change .. • 03-
in renin .59 .37 1. 12 • 36 
release 
(ng/mg/hr) 
from 
controls 
p:::*** .96 .03 . 10 • 001 
n= 24.0 31.0 6.a 31 
* + +** + .ai!: +.as± +.as:!: Change .. . a3-
in c-AMP . as .a3 .as .04 
(pMol/mg) 
from 
controls 
p:;;*** .4a .a4 • 35 .a4 
n= 24.a 31.a 6.a 31 
* Difference in relation to control values. 
+ 
** - Standard error. 
*** Number of observations. 
(10- 11 M, -9 -7 10-JM) 10 M, 10 M, in the presence and 
and c-AMP content of kidney slices from sodium-
10- 7M 10-9M 10=~M -11 -11 iso. iso. 10 M 10 M iso. 
10-6M phen. iso. 10 M phen. iso. 10-6M phen. 
±.61± + .38± + .87:!: + .1o± +1.86:!: 
2.59 . 33 1. 34 • 32 1. 44 
.82 .25 .55 .77 .25 
6.a 31.a s.a 31.0 6.a 
+.21:!: + .as:!: + -.a3:!: -.as± -.03-
.06 .a4 .08 .05 .a7 
. a 1 .a6 • 71 .46 .49 
6.a 31.a s.a 31.0 6.a 
CHAPTER V 
DISCUSSION 
A renal cortical slice preparation of the type 
described in this study allows one to eliminate the various 
humoral and hemodynamic factors which are known to influence 
renin release in the intact animal. Thus, the effects of 
sympathetic stimuli on renin release may be considered to be 
exerted directly on the juxtaglomerular cells present in an 
in vitro kidney slice system (5, 7, 44). Furthermore, 
animals maintained on sodium-deficient diets have shown an 
increased basal resting renin release rate (12, 46), as 
compared to animals fed a sodium-replete diet. In addition, 
sodium-deficiency has been shown to potentiate the renin 
release responses to sympathetic stimuli (5), which makes a 
cortical slice preparation obtained from sodium-deficient 
rats an ideal tool for a clear evaluation of the effects of 
adrenergic agents on renin secretion. 
The results obtained in an initial study (figure 1) 
confirm previous data (9, 12) which indicate that the resting 
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renin release rate in kidney slices of rats maintained on a 
sodium deficient diet is significantly higher than that seen 
in sodium-replete animals. These results (figure 1) also 
show that sodium-deficiency did not alter the c-AMP content 
levels of the tissue slices, suggesting that the increased 
resting renin secretory rates observed under low sodium 
conditions may not be mediated by changes in the intra-
cellular concentration of this nucleotide. 
In a subsequent study designed to examine the renin 
secretory responses to sympathetic stimuli in the sodium-
replete state various concentrations (lo-13M to 10-3M) of 
the specific beta-adrenoreceptor agonist 1-isoproterenol 
added to kidney slices from sodium-replete rats were evalu-
ated. These results (figure 2) indicate that although the 
mean renin release responses to increasing isoproterenol 
-7 -3 doses (10 M to 10 M) were consistently higher than control 
values, the increases were not of sufficient magnitude to be 
statistically significant. Similar results were observed in 
regard to tissue c-AMP changes in slices from sodium-replete 
rats in responses to the same concentrations of isopro-
terenol (figure 3). 
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The inability of the tissue slice preparation 
obtained from sodium-replete rats to respond to isopro-
terenol stimulation in this study is not surprising, since 
renin secretory mechanisms are very sensitive to sodium 
changes and these animals had ingested a diet providing over 
2.2 mEq of sodium per day, which is about 12 times the 
amount of sodium recommended by the National Research 
Council for growing rats. Our results are supported by the 
work of Nash (24, 32) in which infusion of sodium chloride 
in live dogs resulted in a significant decrease in renin 
secretion. Thus, it appears that the increased sodium 
content of the diet fed to the animals used in this study is 
most likely responsible not only for the low levels of renin 
secretion observed in renal slices from these animals, but 
also for the lack of responses of the slice tissue to 
isoproterenol stimulation. 
In another study, the effects of various concen-
-13 -3 trations (10 M to 10 M) of 1-isoproterenol on renin 
release in kidney slices from sodium-deficient rats were 
evaluated (figure 4). As opposed to the results observed in 
tissue slices from sodium-replete rats upon addition of 
isoproterenol, four concentrations of this catecholamine 
(10-7M, 10-5M, 10-4M, and 10-3M) significantly stimulated 
renin release in slices from sodium-deficient rats. At no 
time was inhibition of renin release by high isoproterenol 
doses seen in this study, as opposed to that seen with 
norepinephrine in other studies (7, 9). These data (figure 
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4) support previous in vivo (11, 12) and in vitro (7, 9) 
observations, suggesting a potentiation of the renin secretory 
responses in sympathetic stimuli in sodium~deficient animals. 
Furthermore, these results show a clear dose-response relation-
ship which rules out leakage of renin from the cells as a 
contributing factor in the responses observed. 
When the renin release responses to the four stimula-
tory concentrations of isoproterenol are compared to the 
c-AMP content changes seen in response to the same isopro-
terenol doses (figure 5), a clear correlation between these 
two parameters can be observed. These results provide 
strong support for the concept that stimulation of renin 
secretion by catecholamines is mediated by a beta-adrenoreceptor 
mechanism which utilizes intracellularly generated c-AMP as 
a second messenger of the catecholamine action. In addition, 
these data (figure 5) are in agreement with previous work 
(7, 9) which have shown a correlation between renin release 
and c-AMP content changes in response to norepinephrine 
added to kidney slices from sodium-deficient rats. 
To further extend these observations, the effect of 
the specific beta-adrenoreceptor blocking agent d,l-pro-
pranolol (10-4M}, added either alone or in conjunction with 
isoproterenol, on renin release and tissue c-AMP content of 
slices from sodium-deficient rats was examined (figure 6}. 
These results support previous findings (1, 10, 42, 49} 
indicating that propranolol suppresses the stimulatory 
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effect of catecholamines on renin secretion. This inhibition 
can clearly be seen in this study at an isoproterenol dose 
-7 
of 10 M, although a higher concentration of this catecholamine 
-3 (10 M} appeared to be sufficiently potent to override the 
inhibitory effect of propranolol at the concentration used 
(10- 4M}. These data (figure 6) also present evidence for 
the first time clearly linking the inhibitory effect of 
propranolol on renin secretion with a simultaneous inhibition 
of tissue c-AMP content, which strongly support the concept 
that catecholamine stimulation of renin secretion is mediated 
by a beta-adrenoreceptor complex most likely located on the 
membranes of the juxtaglomerular cells themselves. 
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-4 Interestingly, propranolol (10 M) added alone to 
the tissue slice preparation (figure 6) significantly inhibited 
c-AMP content levels in relation to those seen in control 
(non-treated), slices, and mean renin secretory rates in 
response to this blocking agent also appeared decreased but 
not significantly. These observations suggest that endo-
genous catecholamines still present in the cortical slice 
tissue, contribute to the regulation of basal renin secre-
tion in the sodium-deficient state. 
The results obtained in an additional study involving 
the use of the specific alpha-adrenoreceptor blocking agent 
phentolamine are inconclusive (Table 1). Numerous studies 
(4, 7-9, 15) have shown that alpha-adrenoreceptor blockade 
potentiates the renin secretory responses to sympathetic 
stimuli. In our studies phentolamine did not potentiate but 
rather prevented the stimulatory effect of two isoproterenol 
-7 3 doses (10 M and 10- M) on renin release. Its effect on 
tissue c-AMP content, however, was only partial since in the 
-6 -7 presence of phentolamine (10 M) plus isoproterenol (10 M), 
tissue c-AMP content levels remained significantly elevated. 
It should be pointed out, however, that although phento-
lamine appeared to prevent the stimulatory effect of 10-7M 
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-3 
and 10 M isoproterenol on renin release, the mean renin 
secretory rates observed in the presence of this blocking 
agent concomitant with two different doses of isoproterenol 
were no different from those seen with isoproterenol added 
alone, but the standard errors were larger in the former. 
Thus, statistics notwithstanding, one could suggest that 
stimulation of renin secretion by isoproterenol with simul-
taneous addition of phentolamine was maintained to a certain 
degree, but that it certainly was not potentiated. Further 
studies utilizing additional doses of phentolamine are 
clearly needed to further evaluate the responses observed in 
our study at the concentration of phentolamine used. 
In summary, the data presented in this thesis 
supports the view that sodium deficiency, in addition to 
significantly increasing basal renin release, potentiates 
the renin secretory responses to sympathetic stimulation in 
rat renal cortical slices. This increase in basal renin 
secretory levels as a result of sodium deficiency appears 
not to involve changes in tissue c-AMP content. 
Furthermore, these results offer clear evidence for 
a beta-adrenoreceptor mechanism mediating the effect of 
isoproterenol on renin release, and strongly suggests that 
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this mediation is exerted through changes in intracellularly 
generated c-AMP. 
Additionally, the effect of isoproterenol on renin 
release and c-AMP content appears to be dose-dependent, and 
at no time did higher doses of this agent cause inhibition 
of either parameter as suggested for large concentrations of 
norepinenephrine in previous studies. This observation is 
consistent with the view that alpha- receptors do not par-
ticipate in mediating the effect of large concentrations of 
isoproterenol on renin secretion, a role which appears to be 
inhibitory in nature in regard to high norepinephrine doses. 
If anything, our data pertaining to phentolamine 
would rather support the idea that alpha- adrenoreceptors 
partly mediate the stimulatory effect of isoproterenol on 
renin secretion instead of an inhibitory effect. Additional 
studies with this alpha- adrenergic blocker are needed 
before a more conclusive statement in this regard can be 
made. 
Finally, the data obtained from these series of 
studies utilizing specific beta-adrenoreceptor agonist and 
antagonist agents, add strong support to the concept that 
the sympathetic nervous system directly regulates the secretion 
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of renin from the juxtaglomerular cells of the mammalian 
kidney through a receptor complex located on the membranes of 
these cells which utilizes c-A11P as the intracellular 
mediator. 
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APPENDIX A 
APPENDIX A 
Renin Calculation 
The concentration of renin in the incubated super-
natant medium was calculated as follows: 
picograms A-I from 
ng/mg/hr = std. curve X 40 X 2 X (40, 20, Or 10) X 2.5 
2 X 1000 X mg wet tissue 
where: 
In numerator: 
picograms A-I from std. curve = amount of unknown 
sample read from std. curve •.. 
40 = 
2 = 
40, 20, or 10 = 
2.5 = 
25 microliters of incubated sample diluted 
in one ml of nephrectomized plasma for 
generation •.. 
1:1 dilution of generated sample with 
water prior to boiling ... 
whether 25, 50, or 100 microliters of 
generated-boiled sample were used for 
RIA ... 
initial dilution in 2.5 ml of Robinson's 
buffer medium prior to 1-hr incubation. 
52 
where: 
In denominator: 
2 
1000 
= 
= 
(mg wet tissue)= 
53 
hours of incubation at 37°C •.. 
conversion of picograms to nanograms ... 
amount of incubated kidney slice tissue. 
APPENDIX B 
APPENDIX B 
Legends 
Figure 1. Changes in renin release and c-AMP content in 
renal cortical slices from sodium-deficient rats 
compared to rats maintained on a sodium-replete diet 
control. Length of high- or low-dietary intake was 2-
3 weeks. The sodium-deficient renin data represents 
the mean change ± S.E. of 124 observations (number of 
slice pairs) compared to 20 observations for the 
sodium-replete data. The corresponding c-AMP data are 
based on 121 observations (sodium-deficient) compared 
to 18 observations (sodium-replete). The sodium-replete 
(control) renin release rate was 1.38± 0.32 ng/mg/hr 
and the c-AMP content was 0.64± 0.12 pMol/mg wet 
tissue, respectively. The incubation time was 60 
minutes. 
Figure 2. Effect of various concentrations of 1-isopro-
terenol on renin release from renal cortical slices 
of sodium-replete rats. The data represent the mean 
renin release change ± S.E. of 10 observations 
54 
55 
(number of slice pairs) for each isoproterenol con-
centration. The mean control (unstimulated) rate of 
renin release was 1.38±0.3 ng/mg/hr during a 60 minute 
incubation period. 
Figure 3. Effect of various concentrations of 1-isopro-
terenol on the c-AMP content of renal cortical slices 
from sodium-replete rats. The data represent the mean 
+ 
c-AMP content change - S.E. of 8-9 observations (number 
of slice pairs) for each isoproterenol concentration. 
The mean control (unstimulated) c-AMP content was 
0.64±0.1 pMol/mg wet tissue for a 60 minute incubation 
period. 
Figure 4. Effect of various 1-isoproterenol doses on renin 
release by renal cortical slices from sodium-deficient 
rats. The data represents the mean renin release 
change ± S.E. of 25-31 observations (number of slice 
pairs) for each isoproterenol dose. The mean control 
(unstimulated) rate of renin release was 4.76± 0.36 
ng/mg/hr during a 60 minute incubation period. 
Figure 5. Effect of various concentrations of 1-isopro-
terenol on renin release and c-AMP content of kidney 
slices from sodium-deficient rats. The renin data 
represents the mean renin release change ± S.E. of 
25-31 observations (number of slice pairs) for each 
isoproterenol dose. The c-AMP data represents the 
mean content change ± S.E. of 25-33 observations 
(number of slice pairs) for each isoproterenol dose. 
The mean control (unstimulated) rate of renin release 
was + 5.08 - 0.23 ng/mg/hr. The mean control c-AMP 
content was 0.48 ± 0.1 pMol/mg wet tissue. The in-
cubation time was 60 minutes. 
Figure 6. Changes in renin release and c-AMP content in 
response to various 1-isoproterenol concentrations, 
-4 
added either alone or together with 10 M d,l-iso-
proterenol to renal cortical slices of rats fed a 
sodium-deficient diet for 2-3 weeks. The renin data 
+ 
represents the mean renin release change - S.E. of 
25-31 observations (number of slice pairs) for each 
isoproterenol dose added alone, and 5-7 observations 
for each isoproterenol dose added together with d,l-
propranolol. The c-AMP data represents the mean 
+ content change - S.E. of 25-33 observations (number of 
slice pairs) for each isoproterenol dose added alone, 
and 6 observations for each isoproterenol dose added 
56 
together with d,l-propranolol. The mean control 
(unstimulated) rate of renin release was 5.08 ±o.23 
ng/mg/hr. The mean control c-AMP content was 0.43 
±o.l pMol/mg wet tissue. The incubation time was 
60 minutes. 
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